FDA：輝瑞虎黴素恐增加死亡風險:－2016 韓國連線批發網 , 韓國連線批發廠商 , 韓國連線批發網站 , 東大門連線批發 , 韓國連線賣家 , 韓國批發 , 韓國連線 , 韓國服飾批發 , 韓國連線教學

Blogtrottr

<<蘋果日報>>即時新聞-娛樂

>即時新聞-娛樂

More Tickets. Better Service. Lower Prices.

Buy or sell tickets for concerts, sports, or theater. You'll find a huge and affordable selection at Ticket Liquidator!

From our sponsors

FDA：輝瑞虎黴素恐增加死亡風險

Sep 28th 2013, 09:09

【綜合報導】美國食品藥物管理局FDA昨天(27日)發出警告，指輝瑞大藥廠(Pfizer)生產的一款抗生素針劑「虎黴素」(Tygacil)，病患使用後會增加死亡風險，輝瑞藥廠必須在藥品包裝上加註「黑框」警告字句，這是風險程度達到最高層級。

FDA表示，只有在替代性治療都無效或不適用的情況下，才應該使用Tygacil。FDA已批准這款藥物用於治療複雜的皮膚與腹腔感染，及社區型細菌性肺炎，但未批准用於治療糖尿病足感染或醫院獲得性肺炎。

輝瑞藥廠生產的虎黴素針劑。翻攝網路

This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers. Five Filters recommends:

Massacres That Matter - Part 1 - 'Responsibility To Protect' In Egypt, Libya And Syria
Massacres That Matter - Part 2 - The Media Response On Egypt, Libya And Syria
National demonstration: No attack on Syria - Saturday 31 August, 12 noon, Temple Place, London, UK

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions